【Objective】 To investigate effects of combined usage of dynamic neuro-electric stimulation(DNES) and M-cholynolytic therapy(oxybutynin) upon manifestations of neurogenic bladder dysfunctions(NBD) in children.【Method】 Urodynamics examination included registration of extemporaneous urinary excretion,urofluometry,and retrograde cytometry in horizontal and vertical position by example of urodynamic system(UDS) ACS 180 Plus(MENFIS BioMed.,USA).In accordance to severity of clinician manifestations,three groups of patients have been defined(27-highest one,49-middle and 51 low levels).Dynamic neuro-electrostimulation(DNES) procedures were conducted using the“DiaDNES-PKM”device(Russian Federation).The children were exposed to juxtaspinal stimulation on S1-S3 level-altogether 10 sessions have been performed.Oxybutynin(driptan) was used in dosage of 2.5 mg per diem.【Result】It was established that combined usage of DNES and oxybutynin in the group with highest severity caused the reduction of manifestations by 3.1 times while separately given DNES and basic therapy were followed by 34.1% and 28.0% reduction correspondently.Meanwhile,DNES and oxybutynin reduced severity in patients with pronounced disturbances by 7.5 times.Combined usage of oxybutynin and DNES in severely manifested NBD increased the effective volume of bladder by 2.3 times.Also significant reduction of both intrabladder pressure(by 48.0%) and compliance of the bladder(by 4.8 times) were detected under condition of combined usage of DNES and oxybutynin.All mentioned indices were modified to less extent in case of separate usage of DNES or oxybutynin when compared with the one registered after the combined their usage(P <0.05).【Conclusion】Combined usage of DENS and oxybutinin(driptan) is effective in most severe cases in children suffered from neurogenic overactive bladder. 【Objective】 To investigate the effects of combined usage of dynamic neuro-electric stimulation (DNES) and M-cholynolytic therapy (oxybutynin) upon manifestations of neurogenic bladder dysfunctions (NBD) in children. 【Method】 Urodynamics examination included registration of extemporaneous urinary excretion, urofluometry, and retrograde cytometry in horizontal and vertical position by example of urodynamic system (UDS) ACS 180 Plus (MENFIS BioMed., USA) .Inwent to clinician manifestations, three groups of patients have been defined (27-highest one, 49-middle and 51 low levels. Dynamic neuro-electrostimulation (DNES) procedures were conducted using the “DiaDNES-PKM” device (Russian Federation). The children were exposed to juxtaspinal stimulation on S1-S3 level-altogether 10 sessions have been performed that combined use of DNES and oxybutynin in the group with highest severity caused the red uction of manifestations by 3.1 times while separately given DNES and basic therapy were followed by 34.1% and 28.0% reduction correspondent. However, DNES and oxybutynin reduced severity in patients with pronounced disturbances by 7.5 times. Covered usage of oxybutynin and DNES in severely manifested NBD increased the effective volume of bladder by 2.3 times. Significant reduction of both intrabladder pressure (by 48.0%) and compliance of the bladder (by 4.8 times) were detected under condition of combined usage of DNES and oxybutynin.All mentioned indices were modified to less extent in case of separate usage of DNES or oxybutynin when compared with the one one registered after the combined their usage (P <0.05). 【Conclusion】 Combined usage of DENS and oxybutin (driptan) is effective in most severe cases in children suffered from neurogenic overactive bladder.